GLP-1 drugs linked to reduced risk of epilepsy
A retrospective analysis of data from adults treated for type-2 diabetes indicates that glucose-lowering GLP-1 drugs could be linked to a lower risk of epilepsy. The findings appeared… read more.
A retrospective analysis of data from adults treated for type-2 diabetes indicates that glucose-lowering GLP-1 drugs could be linked to a lower risk of epilepsy. The findings appeared… read more.
Clinicians may fail to recognize common side effects of drugs like gabapentin — which are frequently prescribed for nerve pain — leading them to prescribe unnecessary medications that… read more.
Treating malignant melanoma with lower doses of approved immunotherapy appears to result in improved results, while also reducing side effects. Investigators from the Karolinska Institutet in Stockholm, Sweden… read more.
Belgian scientists from VIB and Ghent University (UGent), together with Danish collaborators, have uncovered compelling evidence that early-infancy infection with respiratory syncytial virus (RSV) significantly increases the risk… read more.
In an increasingly acute surgeon shortage, artificial intelligence could help fill the gap, coaching medical students as they practice surgical techniques. A new tool, trained on videos of… read more.
A rigorous systematic review of the use of paracetamol (also known as acetaminophen) during pregnancy has found that the common painkiller does not increase the risk of specific… read more.
Companies developing medicines or vaccines targeting antimicrobial resistance (AMR) can now avail of improved scientific advice from the European Medicines Agency (EMA). The new approach brings together expertise… read more.
The European Medicines Agency’s key committee on human medicines (CHMP) recommended ten medicines for approval at its November 2025 meeting. This brings to 97 the total number of… read more.
The EU drug watchdog, the European Medicines Agency (EMA), has launched a partnership with social media influencers to promote the safe use of GLP-1 receptor agonists. The #HealthNotHype… read more.
In humans, CBD is thought to have therapeutic effects for some conditions including chronic pain, nausea, or inflammation. Now, dogs may be reaping some of the benefits, too,… read more.
Long-term exposure to toxic air can substantially weaken the health benefits of regular exercise, suggests a new study by an international team including UCL (University College London) researchers. The… read more.
Original Research Background: In this study, researchers aimed to understand how general practitioners experience trust in their patients, and how that trust affects patient care. Researchers interviewed 25… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.